Vimarsana
Biggest News Aggregation in the World

Page 2 - Query Get News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Query Get. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Query Get Today - Breaking & Trending Today

Partnership expands to develop new prescription digital therapeutic for schizophrenia - Vimarsana News

Partnership expands to develop new prescription digital therapeutic for schizophrenia

Boehringer Ingelheim and Click Therapeutics have announced the launch of an expanded collaboration for development and commercialization of a second prescription digital therapeutic for those diagnosed with schizophrenia. According to a release from Boehringer, the collaboration intends to produce a novel mobile application that combines multiple clinically validated therapeutic interventions

Source: healio.com
Related Topics:
Query Get
Few young people with cancer receive fertility preservation counseling - Vimarsana News

Few young people with cancer receive fertility preservation counseling

ANAHEIM, Calif. — Among adolescent and young adult inpatients with cancer, sex, age and insurance type affected the likelihood of consultation and election of fertility preservation, data presented here showed.

Source: healio.com
Related Topics:
Query Get
Top in hem/onc: Cell therapy approaches; low colorectal cancer screening rates - Vimarsana News

Top in hem/onc: Cell therapy approaches; low colorectal cancer screening rates

Strategies for cell therapy to treat cancer very depending on the type of tumor, according to experts.

Source: healio.com
Novel agent demonstrated tolerability, clinical response in patients with advanced NSCLC - Vimarsana News

Novel agent demonstrated tolerability, clinical response in patients with advanced NSCLC

For patients with advanced non-small cell lung cancer who showed an inadequate response to front-line immunotherapy checkpoint inhibitors and chemotherapy, the addition of CAN-2409 was well-tolerated. The preliminary clinical data of CAN-2409, a replication-deficient adenoviral gene construct that delivers the thymidine kinase gene, was presented at ASCO Annual Meeting.

Source: healio.com
More data needed on sex, gender differences in stroke treatment, outcomes - Vimarsana News

More data needed on sex, gender differences in stroke treatment, outcomes

Endovascular therapy is now a standard treatment for select patients with severe ischemic stroke to improve the likelihood of functional recovery; yet there remains a paucity of research on outcomes by sex and gender.The American Heart Association in June published a scientific statement on sex- and gender-related differences in endovascular stroke treatment in Stroke. The statement

Source: healio.com